Search Results

Researchers at the Francis Crick Institute and GSK will extend their ongoing collaboration to advance the discovery of new drug targets in a £11.5million effort, thanks to a ‘Prosperity Partnership’ grant from the Engineering and Physical Sciences Research Council (EPSRC) and matching funds from GSK.

Ten innovative startups, operating at the intersection of data and biomedical science, have been selected to take part in the KQ Labs accelerator programme.

KQ Labs opens applications for early stage data-driven health start-ups for its fourth annual accelerator programme.

KQ Labs, an accelerator programme focused on data-driven health, run by the Crick and now funded by LifeArc, has selected ten new start-ups for its third cohort.  

Innovate UK is investing £400,000 to launch KQ Labs, an accelerator programme at the Francis Crick Institute to support start-ups working at the interface between biomedical and data science.

Ervaxx, a cancer therapy company based on the work of the Crick’s George Kassiotis, has launched today.

Artios Pharma Limited (Artios), a biotech company established with the help and expertise of Francis Crick Institute senior group leader Simon Boulton, is to partner with Merck.

Takeda Pharmaceutical Company Limited today announced the exercise of its option to acquire GammaDelta Therapeutics Limited, a company focused on exploiting the unique properties of gamma delta T cells for immunotherapy.

10 innovative start-up companies working at the interface of biomedical and data science are to receive personalised mentoring and coaching as part of the KQ Labs accelerator programme.